Age-related macular degeneration and recent developments: new hope for old eyes?
- 1 May 2007
- journal article
- review article
- Published by Oxford University Press (OUP)
- Vol. 83 (979), 301-307
- https://doi.org/10.1136/pgmj.2006.052944
Abstract
Age-related macular degeneration (AMD) is the commonest cause of blindness in the population over 60 years of age and accounts for over 50% of those registered blind in the UK. The incidence is increasing and as older generations live longer a growing number of patients will be affected in the future. Affected patients lose central vision, important in all aspects of everyday life. This review outlines risk factors for AMD, clinical features, treatment and management strategies for patients, families and physicians caring for those with AMD. Recent trials are included along with practical clinical advice. While there is no curative treatment at present, intervention can reduce the risk of developing AMD and limit disease progression if it occurs. These modalities are discussed here. As new discoveries in the field of genetics and novel therapies emerge, a brighter future seems certain for the ageing population.Keywords
This publication has 52 references indexed in Scilit:
- Ranibizumab for Neovascular Age-Related Macular DegenerationThe New England Journal of Medicine, 2006
- Intravitreal Avastin: The Low Cost Alternative to Lucentis?American Journal of Ophthalmology, 2006
- Transpupillary thermotherapy for the treatment of occult CNV in age‐related macular degeneration: a prospective randomized controlled pilot studyActa Ophthalmologica Scandinavica, 2006
- Long term results after transpupillary thermotherapy in eyes with occult choroidal neovascularisation associated with age related macular degeneration: a prospective trialBritish Journal of Ophthalmology, 2006
- Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Ophthalmic findings: SST report no. 11Ophthalmology, 2004
- Change in visual function after macular translocation with 360° retinectomy for neovascular age-related macular degenerationOphthalmology, 2004
- Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomesOphthalmology, 2003
- Risk of Incident Age-related Eye Diseases in People with an Affected Sibling : The Beaver Dam Eye StudyAmerican Journal of Epidemiology, 2001
- MACULAR TRANSLOCATION WITH 360-DEGREE PERIPHERAL RETINECTOMYRetina, 2001
- Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degenerationOphthalmology, 1998